Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Single-dose Pharmacokinetics of Eluxadoline in Healthy Participants With Normal Renal Function and Participants With Renal Impairment.
Journal: Clinical pharmacology in drug development
Published: June 06, 2022
An Open-Label Study to Evaluate the Effect of Eluxadoline on the Single-Dose Pharmacokinetics of Midazolam in Healthy Participants.
Journal: Clinical pharmacology in drug development
Published: April 12, 2022
Linaclotide utilization and potential for off-label use and misuse in three European countries.
Journal: Therapeutic advances in gastroenterology
Published: December 15, 2021
Post-marketing reports of pancreatitis in eluxadoline-treated patients pre and post US label change.
Post-marketing reports of pancreatitis in eluxadoline-treated patients pre and post US label change.
Journal: Therapeutic advances in gastroenterology
Published: February 12, 2021
Safety and tolerability of linaclotide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation: pooled Phase 3 analysis.
Journal: Expert review of gastroenterology & hepatology
Published: February 23, 2019
Minimal diversity of drug-resistant Mycobacterium tuberculosis strains, South Africa.
Journal: Emerging infectious diseases
Published: February 26, 2014
Nosocomial transmission of extensively drug-resistant tuberculosis in a rural hospital in South Africa.
Journal: The Journal of infectious diseases
Published: November 21, 2012
Showing 1-7 of 7
Last Updated: 09/26/2026